Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01791283
Other study ID # FourCompv1
Secondary ID
Status Completed
Phase N/A
First received February 12, 2013
Last updated February 12, 2013
Start date August 2012
Est. completion date February 2013

Study information

Verified date February 2013
Source University Hospital, Linkoeping
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Observational

Clinical Trial Summary

Real-time comparison of three different bedside strokevolumemeasurements (arterial waveform analysis, eosofageal doppler and 2D transthoracal ultrasound) validated against cardiac magnetic resonance imaging (CMRI)


Description:

20 healthy volounteers between age of 20-40 years, no previous medical history undergo simoultaneous left ventrikular strokevolume measurements using three different methods at rest. After datasampling and without moving, the subject then undergo Cardiac Magnetic Resonance Imaging with 2D-throughplane and cine tecnology for validation of volume measurements. The data is then analyzed using Bland-Altman calculation.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date February 2013
Est. primary completion date February 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:Healthy volounteers age 20-40, BMI < 30, weight < 100 kg, no medications, sinus rythm on ECG, no contra-indications for MRI, ability to give written informed consent.

Exclusion Criteria:

- Heart and/or vascular disease such as angina pectoris, arrythmias, claudicatio intermittens e g.

- Diseases in gastrointestinal tract or nose.

- Coagulopathies

- Pregnancy

- Allergys for local anaesthetics

- Claustrofobia

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Difference in Measured Results Using Four Different Strokevolume Measurements Simultaneously.

Intervention

Procedure:
Arterial waveform analysis, esofageal doppler, transthoracal cardiac ultrasound, Cardiac magnetic resonance imaging.


Locations

Country Name City State
Sweden Departement for intensive care medicine, Universitetssjukhuset Linkoping

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Linkoeping

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Limits of agreement (LOA) is less than 30% using CMRI as validation for each individual measurement of left ventricular stroke volume. Study period (1 month) No